Market Place
Sourcing Support
Elite Pharma Launches Acetaminophen And Codeine Phosphate Tablets
09 Oct 2024 //
PHARMABIZ
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
20 May 2024 //
ACCESSWIRE
Elite Pharma Reports Financial Results for Third Quarter of Fiscal Year 2024
14 Feb 2024 //
ACCESSWIRE
Elite Pharma to Host Conference to Discuss Third Quarter 2024 Financial Results
08 Feb 2024 //
ACCESSWIRE
Elite Files ANDA with US FDA to Market Central Nervous System Stimulant
26 Dec 2023 //
ACCESSWIRE
Elite Announces First Product Shipment of Generic Adderall XR(R)
12 Dec 2023 //
ACCESSWIRE
Elite Pharma Reports Financial Results for Second Quarter of Fiscal Year 2024
14 Nov 2023 //
ACCESSWIRE
Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results
10 Nov 2023 //
ACCESSWIRE
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
25 Sep 2023 //
ACCESSWIRE
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
07 Sep 2023 //
ACCESSWIRE
Elite PharmaReports Positive Results from a Pivotal Bioequivalence Study
28 Aug 2023 //
ACCESSWIRE
Elite Pharma Reports Financial Results for First Quarter of Fiscal Year 2024
14 Aug 2023 //
ACCESSWIRE
Elite to Discuss First Quarter 2024 Financial Results on August 15, 2023
09 Aug 2023 //
ACCESSWIRE
Elite Pharmac Reports Financial Results for the Fiscal Year Ended March 31
29 Jun 2023 //
ACCESSWIRE
Elite Pharma to Host Conference Call to Provide Corporate Update
22 Jun 2023 //
ACCESSWIRE
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product
20 Apr 2023 //
ACCESSWIRE
Elite Reports Financial Results for the Third Quarter of Fiscal Year 2023
14 Feb 2023 //
ACCESSWIRE
Elite to Host Conference to Discuss Third Quarter 2023 Financial Results
08 Feb 2023 //
ACCESSWIRE
Elite Pharma Reports Positive Results from a Pivotal Bioequivalence Study
07 Feb 2023 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.